Name | Value |
---|---|
Revenues | 37.7M |
Cost of Revenue | 33.6M |
Gross Profit | 4.1M |
Operating Expense | 6.3M |
Operating I/L | -2.2M |
Other Income/Expense | -0.6M |
Interest Income | 0.8M |
Pretax | -2.7M |
Income Tax Expense | -0.6M |
Net Income/Loss | -2.1M |
Avid Bioservices, Inc. is a contract development and manufacturing organization specializing in biopharmaceutical drug substances derived from mammalian cell culture. The company offers process development, current good manufacturing practices (CGMP) clinical and commercial manufacturing services, including monoclonal antibodies and recombinant proteins production, CGMP drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission support. Additionally, it provides process development services such as upstream and downstream development, optimization, and analytical methods development. Avid Bioservices, Inc. caters to the biotechnology and biopharmaceutical industries, generating revenue through its comprehensive range of manufacturing and development services.